Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study.

Autor:	Kendall PC; Department of Psychology, Temple University., Cummings CM; Department of Psychology, Temple University., Villabø MA; Department of Psychology, Center for Child and Adolescent Mental Health., Narayanan MK; Department of Psychology, The Norwegian Center for Child Behavioral Development., Treadwell K; Department of Psychology, University of Connecticut., Birmaher B; Department of Psychiatry, University of Pittsburgh., Compton S; Department of Psychiatry and Behavioral Sciences, Duke University., Piacentini J; Department of Psychiatry and Behavioral Sciences, University of California, Los Angeles., Sherrill J; Child and Adolescent Mental Health, National Institute of Mental Health., Walkup J; Department of Child and Adolescent Psychiatry, Cornell University., Gosch E; Department of Psychology, Philadelphia College of Osteopathic Medicine., Keeton C; Department of Child and Adolescent Psychiatry, Johns Hopkins University., Ginsburg G; Department of Child and Adolescent Psychiatry, Johns Hopkins University., Suveg C; Department of Psychology, University of Georgia., Albano AM; Department of Child and Adolescent Psychiatry, Columbia University.
Jazyk:	angličtina
Zdroj:	Journal of consulting and clinical psychology [J Consult Clin Psychol] 2016 Jan; Vol. 84 (1), pp. 1-14. Date of Electronic Publication: 2015 Oct 12.
DOI:	10.1037/a0039773
Abstrakt:	Objective: Test changes in (a) coping efficacy and (b) anxious self-talk as potential mediators of treatment gains at 3-month follow-up in the Child/Adolescent Anxiety Multimodal Treatment Study (CAMS). Method: Participants were 488 youth (ages 7-17; 50.4% male) randomized to cognitive-behavioral therapy (CBT; Coping cat program), pharmacotherapy (sertraline), their combination, or pill placebo. Participants met Diagnostic and Statistical Manual for Mental Disorders-Fourth Edition (DSM-IV) criteria for generalized anxiety disorder, social phobia, and/or separation anxiety disorder. Coping efficacy (reported ability to manage anxiety provoking situations) was measured by youth and parent reports on the Coping Questionnaire, and anxious self-talk was measured by youth report on the Negative Affectivity Self-Statement Questionnaire. Outcome was measured using the Pediatric Anxiety Rating Scale (completed by Independent Evaluators blind to condition). For temporal precedence, residualized treatment gains were assessed at 3-month follow-up. Results: Residualized gains in coping efficacy mediated gains in the CBT, sertraline, and combination conditions. In the combination condition, some unique effect of treatment remained. Treatment assignment was not associated with a reduction in anxious self-talk, nor did anxious self-talk predict changes in anxiety symptoms. Conclusions: The findings suggest that improvements in coping efficacy are a mediator of treatment gains. Anxious self-talk did not emerge as a mediator. ((c) 2015 APA, all rights reserved).)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu